Xiaohan Zhou
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA modifications and cancer 5
- Extracellular vesicles in disease 4
- Oncology 16
- Peptidase Inhibition and Analysis 5
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Yuanjue Sun (2 shared papers)Lu Yue (2 shared papers)Liwei Wang (2 shared papers)Weiyi Huang (2 shared papers)Yi Cheng (8 shared papers)Chengdong Liu (9 shared papers)Dehua Wu (8 shared papers)Li Liu (7 shared papers)
- Journals
- Frontiers in Oncology (3 papers)The Journal of Heart and Lung Transplantation (2 papers)Frontiers in Immunology (2 papers)Oncogene (2 papers)Journal of Cellular Physiology (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaohan Zhou
57 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 114
- Cancer Research 169
- Biomaterials 147
- Oncology 247
- Molecular Medicine 46
- Molecular Biology 600
Countries citing papers authored by Xiaohan Zhou
This map shows the geographic impact of Xiaohan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohan Zhou more than expected).
Fields of papers citing papers by Xiaohan Zhou
This network shows the impact of papers produced by Xiaohan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohan Zhou. The network helps show where Xiaohan Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaohan Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 129 | |
| 2 | Prognostic value of CRM1 in pancreas cancer. | 2009 | 124 |
| 3 | 2020 | 110 | |
| 4 | 2021 | 63 | |
| 5 | 2017 | 55 | |
| 6 | 2018 | 54 | |
| 7 | 2021 | 45 | |
| 8 | 2019 | 40 | |
| 9 | 2021 | 39 | |
| 10 | 2021 | 36 | |
| 11 | 2019 | 35 | |
| 12 | 2020 | 34 | |
| 13 | 2020 | 31 | |
| 14 | 2024 | 30 | |
| 15 | 2019 | 30 | |
| 16 | 2012 | 29 | |
| 17 | 1997 | 27 | |
| 18 | 2022 | 27 | |
| 19 | 2021 | 25 | |
| 20 | 2020 | 24 |
About Xiaohan Zhou
Xiaohan Zhou is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 60 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (6 papers), Peptidase Inhibition and Analysis (5 papers), Cancer-related molecular mechanisms research (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), RNA modifications and cancer (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Extracellular vesicles in disease (4 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (169 citations), Biomaterials (147 citations), Oncology (247 citations), Molecular Medicine (46 citations) and Molecular Biology (600 citations). Xiaohan Zhou has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yuanjue Sun, Lu Yue, Liwei Wang, Weiyi Huang, Yi Cheng, Chengdong Liu, Dehua Wu, Li Liu, Yuting Chen and Kun Shi. Their work appears in journals such as Frontiers in Oncology, The Journal of Heart and Lung Transplantation, Frontiers in Immunology, Oncogene and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.